HANNAH BUEHLER: Open Payments
NPI 1780342535 · SNELLVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,111 in 107 payments from 20 companies in 2025. Trend: 2023 $2,835 · 2024 $2,905 · 2025 $2,111
Food & beverage: $2,111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $347 |
| UCB, Inc. | 11 | $277 |
| Novartis Pharmaceuticals Corporation | 10 | $277 |
| Incyte Corporation | 7 | $152 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $120 |
| PFIZER INC. | 6 | $111 |
| Arcutis Biotherapeutics, Inc. | 5 | $109 |
| GENZYME CORPORATION | 3 | $107 |
| Janssen Biotech, Inc. | 4 | $94 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $91 |
Products named: Bimzelx, RINVOQ, OPZELURA, TREMFYA, DUPIXENT, Rhapsido, CIBINQO, Zoryve.
Industry payments across GA — which companies pay providers there.
